Common heart drug could be repurposed to treat soft tissue sarcoma
Researchers at Texas Tech University Health Sciences Center (Lubbock, TX, USA) have potentially discerned that a common heart drug could be repurposed as a cost-effective treatment for rare soft tissue sarcomas.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.